Skip to main content
European Commission logo print header

Arrhythmogenic right ventricular cardiomyopathy / dysplasia: clinical registry and data base, evaluation of therapies, pathology registry, dna banking.

Objectif

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive, genetically determined cardiac disease that is a major cause of unexpected sudden death in the young and athlete in Europe. Because of its rarity, there is a need to collect data on a large scale, to set up a clinical and pathological registry to evaluate different treatments and to create a bank of DNA from affected families. The proposed research is a multidisciplinary multicenter collaborative study to investigate clinico-pathologic and genetic aspects of ARVC/D with these aims:
a) prospective longitudinal follow-up study to identify patients at risk of cardiac arrest;
b) evaluation of different therapies efficacy;
c) ultra structural and molecular pathology study to understand the etiopathogenesis;
d) genetic studies with the ultimate goal to identify the specific defective genes and the influence of the genotype on the clinical course.

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

UNIVERSITA DEGLI STUDI DI PADOVA
Contribution de l’UE
Aucune donnée
Adresse
Via Gabelli 61
35121 Padova
Italie

Voir sur la carte

Coût total
Aucune donnée

Participants (8)